Page last updated: 2024-11-08

4,4,4-trifluorovaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4,4,4-trifluorovaline: RN refers to DL-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID259831
SCHEMBL ID189157
MeSH IDM0421190

Synonyms (26)

Synonym
nsc-90439
nsc90439
16063-79-9
NCIOPEN2_001524
4,4,4-trifluorovaline
2365-79-9
2-amino-4,4,4-trifluoro-3-methylbutanoic acid
2-azanyl-4,4,4-tris(fluoranyl)-3-methyl-butanoic acid
A810157
AKOS005257812
valine,4,4,4-trifluoro-
4,4,4-trifluoro-dl-valine
FT-0616978
SCHEMBL189157
mfcd00021721
J-009738
2-amino-3-trifluoromethylbutyric acid
AKOS032963159
DTXSID20936352
2-amino-4,4,4-trifluoro-3-methylbutanoicacid
AT29102
BS-27491
A878175
2-amino-3-methyl-4,4,4-trifluorobutanoic acid
2-amino-3-methyl-4,4,4-trifluorobutyric acid
CS-0320865
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]